BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28410601)

  • 1. The diagnosis and management of NK/T-cell lymphomas.
    Tse E; Kwong YL
    J Hematol Oncol; 2017 Apr; 10(1):85. PubMed ID: 28410601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK/T-cell lymphomas.
    Tse E; Kwong YL
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):253-261. PubMed ID: 31585625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.
    Tse E; Au-Yeung R; Kwong YL
    Expert Rev Hematol; 2019 Nov; 12(11):927-935. PubMed ID: 31487202
    [No Abstract]   [Full Text] [Related]  

  • 5. How I treat NK/T-cell lymphomas.
    Tse E; Kwong YL
    Blood; 2013 Jun; 121(25):4997-5005. PubMed ID: 23652805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
    Kwong YL; Chan TSY; Tan D; Kim SJ; Poon LM; Mow B; Khong PL; Loong F; Au-Yeung R; Iqbal J; Phipps C; Tse E
    Blood; 2017 Apr; 129(17):2437-2442. PubMed ID: 28188133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of advanced NK/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Hematol Malig Rep; 2014 Sep; 9(3):233-42. PubMed ID: 24924658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies.
    Tse E; Kwong YL
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
    Liang R
    Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Yamaguchi M; Suzuki R; Oguchi M
    Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Kwong YL
    J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review on natural killer/T-cell lymphoma.
    He X; Gao Y; Li Z; Huang H
    Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.
    Tse E; Fox CP; Glover A; Yoon SE; Kim WS; Kwong YL
    Semin Hematol; 2022 Oct; 59(4):198-209. PubMed ID: 36805888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma.
    Li M; Gao C; Li H; Wang Z; Cao Y; Huang W; Li X; Wang S; Yu L; Da W
    Med Oncol; 2011 Sep; 28(3):840-5. PubMed ID: 20414818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.
    Yong W; Zheng W; Zhu J; Zhang Y; Wang X; Xie Y; Lin N; Xu B; Lu A; Li J
    Ann Hematol; 2009 Jul; 88(7):647-52. PubMed ID: 19107482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.